HOME › Analyst Briefings › Analyst Briefing Presentation on the In-Vitro Diagnostics (IVD) market in BRIC (2010 - 2014) to be held on 20th April
Analyst Briefing Presentation on the In-Vitro Diagnostics (IVD) market in BRIC (2010 - 2014) to be held on 20th April
The Medical Device practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the In-Vitro Diagnostics (IVD) market in BRIC (2010 - 2014) to be held on 20th April
The IVD markets of BRIC economies offer immense growth opportunities due to the increasing healthcare budgets of these nations, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases. Despite regulatory hurdles and other restraints such as low consumer awareness and the absence of regulations concerning patient safety, the BRIC IVD market is expected to grow from $2.9 billion in 2009 to $7.2 billion-$7.5 billion in 2014 at a CAGR of ~19%-20% from 2009 to 2014. In comparison, the growth rate of the global IVD market is pegged at only ~5%-6% in the next five years.
Currently, the BRIC IVD market is dominated by established players such as Roche, Abbott, Siemens, Beckman Coulter, and Becton Dickinson. However, domestic players such as Transasia, JMitra, Horiba, Kehua, Mindray have taken the distribution of IVD services from urban areas to the rural areas.
The briefing on the IVD Market in BRIC (2010-2014) will benefit the IVD equipment manufacturers, reagent manufacturers, 3rd party distributors of IVD equipment, public and private IVD associations for manufacturers, IVD associations for pathologists, laboratory associations and technology providers.
“If the BRIC nations can overcome regulatory hurdles, we can expect to see an even better growth rate in these IVD markets, following the rising income levels and the increasing reach of healthcare services coupled with an already high population base. The diagnostics market is expected to dominate the healthcare industry within the emerging economies.” notes MarketsandMarkets.
About us
MarketsandMarkets, a research and consulting firm now onto publishing, is producing high level strategically analyzed 200 page reports about 120 a year. Worldwide, market research reports are primarily sold for numbers, market segmentation and competitive landscape, within the business leaders. MarketsandMarkets reports are equipped with more than 20+ market data summary tables. Our reports of about 200 pages analyze about patents, over 40 companies and micro markets which are collectively exhaustive but mutually exclusive. The analyst working with MarketsandMarkets come from the renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a database of hundred thousand of key industry participants and draw on our relationship with more than 900 market research companies globally. We, at MarketsandMarkets, are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our report, please visit our website (www.marketsandmarkets.com)
Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your successful registration.